We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“These early dropouts make the interpretation of the positive results of the study debatable, because many patients did not reach the end of the 6-month trial. It is possible that the most severely affected patients were not able to tolerate the active treatment regimen, thus artificially enriching the long-term treated population with subjects characterized by a better phenotype.”
No takes yet. Share an insight, caveat, or question.
Marc J.C. Humbert (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: